Our attorneys: Investigate potential claims thoroughly Work with medical experts to evaluate vision damage Handle every step of the legal process, at no cost to you unless we win your case Get a Free Case Review If youve suffered vision loss, pain, or diagnosis of NAION, nAMD or diabetic retinopathy while using Ozempic, Wegovy, or another GLP-1 drug, dont wait
GLP-1 receptor agonists such as semaglutide (marketed under brand names Ozempic, Wegovy, and Rybelsus) and the dual GIP/GLP-1 agonist tirzepatide (marketed under brand names Mounjaro and Zepbound) are FDA-approved prescription medications for specific uses in type 2 diabetes management and, in some cases, chronic weight management
Rybelsus was approved in 2019 for Type 2 diabetes the daily tablet was the first oral GLP-1
MICC Injection A concentrated injection designed to accelerate fat metabolism and increase energy levels
These agents (in particular, GLP-1RAs and SGLT2is) were initially developed for their glucose-lowering action but, over time, have been found to demonstrate protective effects toward other therapeutic targets
